Original Source(s)
Related Content
Can Endotoxin-Targeted Care Improve Sepsis Outcomes?
Biomarker-guided patient selection may help identify patients with sepsis who could benefit from endotoxin-targeted therapy, although confirmatory evidence is still needed.
July 20, 2026
-
3 min
FDA Approves Expanded Liquid Biopsy Panel
Updated liquid biopsy combines genomic and epigenomic profiling for companion diagnostic use across multiple tumor types.
May 20, 2026
-
2 min
Nodular Fasciitis May Mimic Sarcoma
Molecular testing may help avoid overtreatment when benign soft-tissue tumors present with atypical clinical or histologic features.
May 11, 2026
-
4 min
